Harrison C. Brown

411 total citations
15 papers, 301 citations indexed

About

Harrison C. Brown is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Harrison C. Brown has authored 15 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Harrison C. Brown's work include CAR-T cell therapy research (9 papers), Virus-based gene therapy research (8 papers) and CRISPR and Genetic Engineering (4 papers). Harrison C. Brown is often cited by papers focused on CAR-T cell therapy research (9 papers), Virus-based gene therapy research (8 papers) and CRISPR and Genetic Engineering (4 papers). Harrison C. Brown collaborates with scholars based in United States, India and China. Harrison C. Brown's co-authors include Christopher B. Doering, H. Trent Spencer, Shannon L. Meeks, Bagirath Gangadharan, Eric A. Gaucher, J. Fraser Wright, Ernest T. Parker, Shangzhen Zhou, David M. Markusic and Roland W. Herzog and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Nature Biotechnology.

In The Last Decade

Harrison C. Brown

15 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harrison C. Brown United States	10	152	136	111	104	24	15	301
Linping Chen-Wichmann Germany	9	205 1.3×	110 0.8×	57 0.5×	93 0.9×	53 2.2×	14	289
Joseph R. McGill United States	10	266 1.8×	69 0.5×	76 0.7×	54 0.5×	50 2.1×	18	350
Robert Moot United States	7	102 0.7×	98 0.7×	144 1.3×	53 0.5×	54 2.3×	12	230
Francesca Dionisio Italy	6	125 0.8×	101 0.7×	120 1.1×	51 0.5×	103 4.3×	10	261
Luca Basso‐Ricci Italy	7	145 1.0×	90 0.7×	121 1.1×	77 0.7×	104 4.3×	9	314
Kerstin Knies Germany	6	303 2.0×	80 0.6×	80 0.7×	30 0.3×	12 0.5×	8	400
Valentina Vavassori Italy	7	366 2.4×	216 1.6×	132 1.2×	47 0.5×	59 2.5×	10	448
S Podda United States	5	248 1.6×	212 1.6×	126 1.1×	51 0.5×	51 2.1×	8	356
Michael R. Greene United States	5	236 1.6×	205 1.5×	104 0.9×	23 0.2×	25 1.0×	8	322
Horacio Nastri United States	10	229 1.5×	69 0.5×	46 0.4×	21 0.2×	35 1.5×	16	287

Countries citing papers authored by Harrison C. Brown

Since Specialization

Citations

This map shows the geographic impact of Harrison C. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harrison C. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harrison C. Brown more than expected).

Fields of papers citing papers by Harrison C. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harrison C. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harrison C. Brown. The network helps show where Harrison C. Brown may publish in the future.

Co-authorship network of co-authors of Harrison C. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Harrison C. Brown. A scholar is included among the top collaborators of Harrison C. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harrison C. Brown. Harrison C. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Brown, Harrison C., et al.. (2023). Humanization and functional characterization of enhanced coagulation factor IX variants identified through ancestral sequence reconstruction. Journal of Thrombosis and Haemostasis. 22(3). 633–644. 2 indexed citations

Fedanov, Andrew, Bing Yu, Harrison C. Brown, et al.. (2023). Ligand-based targeting of c-kit using engineered γδ T cells as a strategy for treating acute myeloid leukemia. Frontiers in Immunology. 14. 1294555–1294555. 9 indexed citations

Becker, Scott A., Brian G. Petrich, Bing Yu, et al.. (2023). Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers. Molecular Therapy — Oncolytics. 29. 145–157. 12 indexed citations

Kumar, Sandeep, Jun Xie, Harrison C. Brown, et al.. (2021). Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassette. Molecular Therapy — Methods & Clinical Development. 23. 98–107. 12 indexed citations

Brown, Harrison C., Christopher B. Doering, Roland W. Herzog, et al.. (2020). Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B. Human Gene Therapy. 31(19-20). 1114–1123. 23 indexed citations

Brown, Harrison C., et al.. (2018). Target-Cell-Directed Bioengineering Approaches for Gene Therapy of Hemophilia A. Molecular Therapy — Methods & Clinical Development. 9. 57–69. 37 indexed citations

Brown, Harrison C., et al.. (2016). Effects of FVIII immunity on hepatocyte and hematopoietic stem cell–directed gene therapy of murine hemophilia A. Molecular Therapy — Methods & Clinical Development. 3. 15056–15056. 23 indexed citations

Brown, Harrison C., et al.. (2016). Enhancing the pharmaceutical properties of protein drugs by ancestral sequence reconstruction. Nature Biotechnology. 35(1). 35–37. 80 indexed citations

Brown, Harrison C., et al.. (2016). 728. Tissue-Directed Transgene Engineering for AAV and Lentivector Gene Therapy Approaches. Molecular Therapy. 24. S287–S287. 1 indexed citations

10.

Brown, Harrison C., et al.. (2014). Bioengineered coagulation factor VIII enables long-term correction of murine hemophilia A following liver-directed adeno-associated viral vector delivery. Molecular Therapy — Methods & Clinical Development. 1. 14036–14036. 39 indexed citations

11.

Brown, Harrison C., et al.. (2013). Bioengineered Coagulation Factor VIII Enables Long-Term Correction Of Murine Hemophilia A Following Liver-Directed Adeno-Associated Viral Vector Delivery. Blood. 122(21). 4210–4210. 1 indexed citations

12.

Brown, Harrison C., Bagirath Gangadharan, & Christopher B. Doering. (2011). Enhanced Biosynthesis of Coagulation Factor VIII through Diminished Engagement of the Unfolded Protein Response. Journal of Biological Chemistry. 286(27). 24451–24457. 39 indexed citations

13.

Summers, Ryan J., Shannon L. Meeks, John F. Healey, et al.. (2011). Factor VIII A3 domain substitution N1922S results in hemophilia A due to domain-specific misfolding and hyposecretion of functional protein. Blood. 117(11). 3190–3198. 17 indexed citations

14.

Kutlar, F., et al.. (2011). BCL11A Polymorphism and HbF Response to Hydroxyurea in Adult Patients with Sickle Cell Disease. Blood. 118(21). 1051–1051. 1 indexed citations

15.

Brown, Harrison C., et al.. (2011). Exploratory Study of Haptoglobin Levels by Genotype in Adult Sickle Cell Patients. Blood. 118(21). 2145–2145. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact